AERI - Aerie Pharmaceuticals' (AERI) CEO Raj Kannan on Q1 2022 Results - Earnings Call Transcript

Aerie Pharmaceuticals, Inc. (AERI) Q1 2022 Earnings Conference Call May 5, 2022 5:00 PM ET Company Participants Hans Vitzthum – LifeSci Partners Raj Kannan – Chief Executive Officer Gary Sternberg – Chief Medical Officer Peter Lang – Chief Financial Officer Conference Call Participants Louise Chen – Cantor Serge Belanger – Needham & Company Annabel Samimy – Stifel Stacy Ku – Cowen and Company François Brisebois – Oppenheimer Carly Kenselaar – Citigroup Oren Livnat – H.C. Wainwright Presentation Operator Good afternoon. Thank you for standing by, and welcome to the Aerie Pharmaceuticals’ First Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. Today’s conference will be recorded. It is now my pleasure to turn the floor over to Hans Vitzthum of LifeSci Partners, Aerie’s Investor Relations firm. Please go ahead. Hans

For further details see:

Aerie Pharmaceuticals' (AERI) CEO Raj Kannan on Q1 2022 Results - Earnings Call Transcript